Simplifying Global Compliance
FDA Will Make Its Case for LDT Oversight at Tuesday Hearing
Devices & Diagnostics Letter
CDRH Director Jeffrey Shuren will defend the FDA’s proposal to regulate laboratory-developed tests during a Sept. 9 hearing on Capitol Hill.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing